SEC Filing Summary: Old Republic International Corp
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Old Republic International Corp to the U.S. Securities and Exchange Commission. The reporting period covers the quarter ended March 31, 2026. The document discloses the company's holdings in equity securities, detailing the number of shares, value, and voting authority for each position.
Key Financial Metrics and Portfolio Composition
The filing does not report Old Republic International Corp's own revenue, profit, cash flow, or debt metrics. Instead, it provides a snapshot of the company's investment portfolio. Key observations include:
- Portfolio Scope: The filing lists 52 distinct equity positions across various sectors, including Utilities, Healthcare, Consumer Staples, Energy, and Industrials.
- Largest Holdings by Value:
- Pfizer: 1,963,700 shares valued at approximately $108.2 million.
- Brown-Forman (Class B): 1,103,400 shares valued at approximately $32.2 million.
- Coca-Cola: 991,300 shares valued at approximately $74.7 million.
- OGE Energy: 862,500 shares valued at approximately $35.7 million.
- Voting Authority: Old Republic International Corp reports Sole voting authority for all listed positions. No shared or none voting authority is reported.
- Derivatives: No put or call options are reported in this filing.
Material Changes and Comparisons
The filing text provided does not contain comparative data from the prior quarter (December 31, 2025). Therefore, material changes in share counts, values, or the addition/removal of positions cannot be determined from this document alone.
Guidance, Outlook, and Risks
As a Form 13F, this document is a regulatory disclosure of holdings and does not contain management commentary, forward-looking guidance, risk factors, or contingency plans regarding Old Republic International Corp's operations. The filing includes a standard disclaimer that the SEC has not reviewed the information for accuracy or completeness.
Investor Verification Checklist
- Verify the total aggregate value of the reported portfolio against the company's latest 10-Q or 10-K to assess the proportion of assets held in equities.
- Compare the share counts listed here with the previous quarter's Form 13F to identify significant buying or selling activity.
- Confirm the valuation methodology used for the "Value" column, as Form 13F values are typically based on the last trading day of the quarter.
- Review the company's 10-Q for the quarter ended March 31, 2026, to obtain actual financial performance metrics (revenue, earnings, cash flow) which are absent in this filing.